Table 5.
Hormonal therapy.
| Année | Number of patients | Age | Rx Pre-surgery | Time (month) | Traitement | Rx Post-surgery | Time | Follow-up (months) | Récurrence |
|---|---|---|---|---|---|---|---|---|---|
| Shin et al. (67) | 1 | 33 | Danazol and GnRHa | 2 | Radical hysterectomy + bilateral oophorectomy with partial excision with cautherization of perineal lesions | local estrogens | NA | 6 | No |
| Liang et al. (2) | 1 | 30 | Danazol 800 mg | 1 | Excision | / | / | 12 | No |
| 1 | 33 | Danazol irregularly | NA | Excision | / | / | 12 | No | |
| Katz et al. (61) | 1 | 14 | Oral contraceptives | NA | Excision | / | / | 4 | No |
| Kang et al. (31) | 1 | 32 | GnRHa | 3 | Excision | / | / | NA | NA |
| Yogini et al. (35) | 1 | 34 | / | / | Drainage and excision | GnRHa | NA | NA | NA |
| Kahraman et al. (38) | 1 | 19 | / | / | Complete excision | Oral contraceptives | 3 | 3 | 1 |
| Zhu et al. (93) | 13 | 30.67 | GnRHa | 3–6 | Complete excision | GnRHa | 3–6 | 9–168 | No |
| 7 | GnRHa | 3– 6 | Incomplete excision | GnRHa | 3–6 | 4–12 | 7 | ||
| 1 | Contraceptives 17alpha-hydroxyprogesterone caproate 250 mg im/28 days and tamoxifen 10 mg twice a day | 15 | Complete excision | Contraceptives 17alpha-hydroxyprogesterone caproate 250 mg im/28 days and tamoxifen 10 mg twice a day | 8 | 84 | 1 | ||
| Hazard et al. (14) | 1 | 15 | / | / | Excision | Oral contraceptivew | NA | NA | No |
| Ngu et al. (63) | 1 | 30 | GnRha | 3 | Excision | / | / | NA | NA |
| Ruiz de Gauna et al. (20) | 1 | 32 | / | / | Wide excision | GnRHa | 3 | NA | No |
| Chen et al. (10) | 10 | 33.4 | GnRHa, Nemestran, DMPA | 1– 6 | Narrow excision | GnRHa, Nemestran, DMPA | 1–6 | NA | No |
| 1 | GnRHa | 3 | Narrow excision | IUD-LNG | NA | NA | No | ||
| 9 | GnRHa | 3–5 | Narrow excision | / | / | 12 | 1 | ||
| 2 | / | / | Narrow excision | GnRHa | 4 | NA | No | ||
| 1 | DMPA | 3–6 | Incomplete excision | DPMA | 3–6 | 72 | 1 | ||
| Hakimi et al. (80) | 1 | 28 | / | / | Excision (difficult) | LHRH | 6 | NA | NA |
| Grimstad et al. (24) | 1 | 29 | / | / | Excision | Oral contraceptives | 65 | 72 | 1 |
| Jeyaseelan et al. (83) | 1 | 38 | / | / | Excision | GnRHa | 3 | NA | NA |
| Li et al. (94) | 4 | 34.35 | / | / | Surgical excision | GnRHa | 3 | 12 | 1 |
| 2 | / | / | Surgical excision | Mifepristone | 1 | NA | No | ||
| 1 | / | / | Surgical excision | Progesterone | NA | NA | No | ||
| Sharp et al. (90) | 1 | 39 | / | / | Large biopsy | Dienogest 2 mg | 6 months | NA | NA |
| Baba et al. (55) | 1 | 35 | / | / | Complete excision | GnRH | NA | NA | NA |
| Sharm et al. (89) | 1 | 37 | / | / | Wide excision | GnRHa | 1 | 6 | No |
| Saloum et al. (58) | 1 | 34 | / | / | Excision | GnRHa | 3 | NA | No |
| Wallace et al. (17) | 1 | 42 | / | / | Excision | Oral contraceptives | 12 | 12 | No |
| Liu et al. (96) | 1 | 34 | Marvelon | NA | Complete excision | GnRHa | 3 | 85 | No |
| 12 | 31.8 | / | / | Complete excision | GnRHa | 3–6 | 45.5 | 1 (12 months) | |
| 1 | 37 | Mifepristone | 3 | Complete excision | Mifepristone | 3 | 75 | No | |
| 1 | 38 | GnRHa | 3 | Complete excision | Mifepristone | 3 | 62 | No | |
| 2 | 34.5 | GnRHa | 3 | Complete excision | GnRH | 3 | 46 | No | |
| 2 | 30.5 | GnRHa | 3 to 5 | Complete excision | / | / | 23.5 | No | |
| 88 |